Get started
89bio, Inc.89bio, Inc.89bio, Inc.

89bio, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ETNB chart


Full chart

ETNB upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.05 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.97 USD
Net income (FY)
‪−142.19 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪100.48 M‬
Beta (1Y)
0.56

Employees


Employees (FY)
70
Change (1Y)
+25 +55.56%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−2.03 M‬ USD

About 89bio, Inc.


Sector
Health Technology
CEO
Rohan Palekar
Headquarters
San Francisco
Website
89bio.com
Founded
2018
FIGI
BBG00QKDZ8J5
89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded on January 18, 2018 and is headquartered in San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ETNB news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ETNB is 10.45 USD — it has increased by 4.12% in the past 24 hours. Watch 89bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange 89bio, Inc. stocks are traded under the ticker ETNB.
ETNB stock has risen by 32.61% compared to the previous week, the month change is a 39.76% rise, over the last year 89bio, Inc. has showed a 25.30% increase.
We've gathered analysts' opinions on 89bio, Inc. future price: according to them, ETNB price has a max estimate of 49.00 USD and a min estimate of 12.00 USD. Watch ETNB chart and read a more detailed 89bio, Inc. stock forecast: see what analysts think of 89bio, Inc. and suggest that you do with its stocks.
ETNB reached its all-time high on Mar 4, 2020 with the price of 47.25 USD, and its all-time low was 2.00 USD and was reached on May 3, 2022. View more price dynamics on ETNB chart.
See other stocks reaching their highest and lowest prices.
ETNB stock is 17.00% volatile and has beta coefficient of 0.56. Track 89bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is 89bio, Inc. there?
Today 89bio, Inc. has the market capitalization of ‪1.05 B‬, it has increased by 2.83% over the last week.
Yes, you can track 89bio, Inc. financials in yearly and quarterly reports right on TradingView.
89bio, Inc. is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
ETNB earnings for the last quarter are −1.39 USD per share, whereas the estimation was −0.62 USD resulting in a −122.89% surprise. The estimated earnings for the next quarter are −0.70 USD per share. See more details about 89bio, Inc. earnings.
89bio, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of ‪750.00 K‬ USD. In the next quarter, revenue is expected to reach ‪750.00 K‬ USD.
ETNB net income for the last quarter is ‪−47.97 M‬ USD, while the quarter before that showed ‪−51.68 M‬ USD of net income which accounts for 7.18% change. Track more 89bio, Inc. financial stats to get the full picture.
No, ETNB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 70.00 employees. See our rating of the largest employees — is 89bio, Inc. on this list?
Like other stocks, ETNB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 89bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 89bio, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 89bio, Inc. stock shows the neutral signal. See more of 89bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.